(Q43031164)

English

Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial.

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

based on heuristic

Hepatitis C virus

1 reference

based on heuristic

chronic hepatitis C

1 reference

based on heuristic

Gioacchino Leandro

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Angelo Andriulli

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Francesco Ventrella

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

A Mangi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M R Villani

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N Minerva

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Bacca

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Cela

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V Carretta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V Attino

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Giangaspero

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

441-446

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HCV genotypes in patients with liver disease of different stages and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900024-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(00)00024-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11322207%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43031164&oldid=1596672877"